---
category: news
title: "DEBIOPHARM INVESTS IN VERISIM LIFE'S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH"
excerpt: "Debiopharm (  ), a Swiss biopharmaceutical company, announced today their co-investment in California -based start-up VeriSIM Life's $15 Million Series A Round to advance their mission to accelerate drug development via technology powered by artificial intelligence (AI)."
publishedDateTime: 2022-01-10T18:35:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-debiopharm-invests-verisim-lifes-15m-series-round-advance-/2022/01/10/9523113.htm"
webUrl: "https://www.tmcnet.com/usubmit/-debiopharm-invests-verisim-lifes-15m-series-round-advance-/2022/01/10/9523113.htm"
type: article
quality: 6
heat: 6
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI

related:
  - title: "Debiopharm International SA: DEBIOPHARM INVESTS IN VERISIM LIFE'S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH"
    excerpt: "Funding to support BIOiSIM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans LAUSANNE, Switzerland"
    publishedDateTime: 2022-01-10T18:29:00Z
    webUrl: "https://www.finanznachrichten.de/nachrichten-2022-01/54935953-debiopharm-international-sa-debiopharm-invests-in-verisim-life-s-dollar-15m-series-a-round-to-advance-ai-enabled-drug-research-008.htm"
    type: article
    provider:
      name: Finanznachrichten
      domain: finanznachrichten.de
    quality: 0

secured: "CFeaGB7btrgrbSjP0AFiychp7JWY55Pt3Dl/RG+GPWz2/5DrzxKgsCYb6dWtaZI1Uek/Of77DJ0lCNGodqxdJmQohO3ZtvZLx1T25e88BD+itp2xIIcBt+YCDRBRsmVwhM61ogh56GSK6b7LVxZUNUVDFXTKWGLqg2rpy9MqsF94ImIpA4D+Xhx/5R/p1jO8o5KAtVufd0gvv5zsTMoMa3u1ByvCLxfI80FYwr5eAZFvM7ZF78mR7I0aK20Qxees44o9bBLeGPIJsQwAgbQoYRl8CutPF+V0AsJC13LjeeGRCbPC+ujT4l2IT+CEIcVE8uyw722bXnkFQQ3lGIaGac2KxZ/paqCVUogbXkCXyzc=;BI7RwueNt+Dvqx04vFNFaw=="
---

